Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M182Revenue $M1.1Net Margin (%)-924.0Z-Score-31.9
Enterprise Value $M204EPS $-0.4Operating Margin %-785.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-924.0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsY
Price/Sales40.35-y EBITDA Growth Rate %97.4Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-129.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M151ROI % (ttm)-168.4Gross Margin Increase y-yN

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NAVB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0812.04 view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0317.48 view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.36-11.03 view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.43-15.38 view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.34-9.7 view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-38.27 view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-38.27 view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-38.27 view
FORD BRENDAN ADirector 2013-11-08Buy20,000$1.45-16.55 view
LARSON BRENT LEVP, CFO, Treas & Secy 2013-11-08Buy5,000$1.39-12.95 view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® Nov 20 2014
    7:31 am Navidea Biopharma announced that the European Commission has granted marketing authorization... Nov 20 2014
    European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® Nov 20 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials Nov 18 2014
    Navidea Biopharmaceuticals (NAVB) Jumps: Stock Up 7.8% Nov 18 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 13 2014
    10-Q for Navidea Biopharmaceuticals, Inc. Nov 12 2014
    Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum... Nov 11 2014
    Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum... Nov 11 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Nov 06 2014
    Navidea Announces Third Quarter 2014 Financial Results Nov 06 2014
    Navidea Announces Third Quarter 2014 Financial Results Nov 06 2014
    Q3 2014 Navidea Biopharmaceuticals Inc Earnings Release - Before Market Open Nov 06 2014
    Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European... Oct 30 2014
    Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European... Oct 30 2014
    Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European... Oct 30 2014
    Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 Oct 29 2014
    Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 Oct 29 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK